Scientific Education Support

Lymphoma Hub

Education EN ↓ Odcinki: 55

The Lymphoma Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in lymphoma and CLL. Our aim is to enhance knowledge in lymphoma and CLL, through the multichannel dissemination of global advances related to their classification, diagnosis, treatment, and management. Hosted on Acast. See acast.com/privacy for more information.

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: lymphomahub.com

Autor

Scientific Education Support

Kategoria

Education

Strona podcastu

lymphomahub.com

Ostatni odcinek

22 wrz 2026

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Zainstaluj za darmo Android prawie 10 mln pobrań · ocena 4,8 iOS niedługo

Odcinki

Is there a role for PET-CT-directed therapy in DLBCL? 17.12.2020 15:40

During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the Lymphoma Hub spoke to Judith Trotman, Concord Repatriation General Hospital, Sydney, AU. We asked, Is there a role for positron emission tomography (PET)-computed tomography-directed therapy in diffuse large B-cell lymphoma (DLBCL)? In this podcast, Trotman starts by explaining the role of PET in staging of DLB...

Can we eliminate auto-SCT for patients with MCL? 11.11.2020 5:35

During the European School of Haematology (ESH)'s   2nd How to Diagnose & Treat Lymphoma conference, the Lymphoma Hub spoke to Marco Ladetto, SS Antonio e Biagio e Cesare Arrigo, Alessandria, IT, who discussed the role of autologous stem cell transplant (auto-SCT) for mantle cell lymphoma (MCL) in 2020. Marco Ladetto starts by introducing what role auto-SCT plays in MCL and indicates that...

Can we avoid chemotherapy entirely in follicular lymphoma? 09.11.2020 11:36

During the European School of Haematology (ESH)'s 2nd How to Diagnose & Treat Lymphoma conference, the Lymphoma Hub spoke to Nathan Fowler, MD Anderson Cancer Center, Houston, US, who discussed the non-chemotherapy approaches to treating follicular lymphoma. Treatment for follicular lymphoma has been improving over recent years. The addition of rituximab, an anti-CD20 antibody, to the clinicia...

An update in CLL from EHA 2020 14.07.2020 6:36

During the 25th European Hematology Association (EHA) Annual Congress, the Lymphoma Hub spoke to Susan O'Brien, University of California Irvine, Orange, US, who discussed the latest updates on chronic lymphocytic leukemia (CLL) from EHA 2020. Highlights in CLL from this year's virtual EHA Annual Congress include 1. Update (~39 months) from the CLL-14 trial (NCT02242942), comparing the safety...

How can we use the microbiome to improve cancer immunotherapy and alleviate side effect such as graft-versus-host-disease 17.06.2020 24:35

During the American Association of Cancer Research (AACR) Virtual Annual Meeting I, the Lymphoma Hub was pleased to speak to Christine Spencer, Parker Institute for Cancer Immunotherapy, San-Francisco, US and Diwakar Davar, University of Pennsylvania Medical Center, Pittsburgh, US. We asked: how can we use the microbiome to improve cancer immunotherapy and alleviate side effects such as graft- ver...